Preprint / Version 1

Validated salivary biomarkers for the diagnosis of gastric cancer: a systematic review

##article.authors##

  • Humberto Muñoz Escuela de Odontología, Facultad de Ciencias de la Salud, Universidad de Talca, Chile https://orcid.org/0000-0002-2546-0834
    • Natalia Zuñiga Escuela de Odontología, Facultad de Ciencias de la Salud, Universidad de Talca, Chile
      • César Rivera Universidad de Talca https://orcid.org/0000-0002-5491-4233

        DOI:

        https://doi.org/10.1590/SciELOPreprints.3174

        Keywords:

        Biomarkers, Saliva, Stomach Neoplasms

        Abstract

        In recent years, saliva has been shown to possess biomarkers capable of diagnosing different diseases, including gastric cancer. Here we present a systematic review (PROSPERO CRD42021259519) with the aim of evaluating biomarkers closer to clinical use. We identified markers of different molecular nature, of which 3 proteins stand out (CSTB, TPI1 and DMBT1), which in the validation stage presented high diagnostic accuracy. Salivary biomarkers have great potential for the detection of stomach cancer; however, it is recommended in subsequent studies to improve the design and execution phases of the research in order to obtain better quality evidence.

        Downloads

        Download data is not yet available.

        Submitted

        11/09/2021

        Posted

        11/12/2021

        How to Cite

        Validated salivary biomarkers for the diagnosis of gastric cancer: a systematic review. (2021). In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.3174

        Section

        Health Sciences

        Plaudit